IP Library Granted Patent US 7,008,631
Granted Patent B2
US 7,008,631 · App. 10/414,808 · Granted Mar 7, 2006

Methods of simultaneously treating ocular rosacea and acne rosacea

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,008,631
App. No.
10/414,808
Granted
Mar 7, 2006
Kind
B2
Abstract

A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially no antibiotic activity.

Claims (3)

1. A method for simultaneously treating ocular rasacea and acne rosacea in a human in need thereof, the method comprising orally or intravenously administering a sub-antimicrobial amount of doxycycline to the human twice a day in a dose of 20 mg, wherein doxycycline is the single agent effective to treat ocular rosacea and acne rosacea.

2. A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof, the method comprising orally or intravenously administering a sub-antimicrobial amount of doxycycline in an amount of 20 milligrams once daily to the human, wherein doxycycline is the single agent effective to treat ocular rosacea and acne rosacea.

3. A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof, the method comprising orally or intravenously administering a sub-antimicrobial amount of doxycycline in an amount of 40 milligrams to the human by sustained release over a 24 hour period, wherein doxycycline is the single agent effective to treat ocular rosacea and acne rosacea.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2011
From: COLLAGENEX PHARMACEUTICALS, INC.
To: GALDERMA LABORATORIES INC.
Reel/Frame 027369/0215 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2008
From: COLLAGENEX PHARMACEUTICALS, INC.
To: GALDERMA LABORATORIES INC.
Reel/Frame 021328/0949 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2003
From: ASHLEY, ROBERT A.
To: COLLAGENEX PHARMACEUTICALS, INC.
Reel/Frame 014340/0113 →